408 related articles for article (PubMed ID: 27858578)
1. Severe cerebral edema following nivolumab treatment for pediatric glioblastoma: case report.
Zhu X; McDowell MM; Newman WC; Mason GE; Greene S; Tamber MS
J Neurosurg Pediatr; 2017 Feb; 19(2):249-253. PubMed ID: 27858578
[TBL] [Abstract][Full Text] [Related]
2. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
[TBL] [Abstract][Full Text] [Related]
3. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
[TBL] [Abstract][Full Text] [Related]
4. Bilateral Optic Neuritis Secondary to Nivolumab Therapy: A Case Report.
Kartal Ö; Ataş E
Medicina (Kaunas); 2018 Nov; 54(5):. PubMed ID: 30404191
[TBL] [Abstract][Full Text] [Related]
5. Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.
Simonelli M; Di Tommaso L; Baretti M; Santoro A
Immunotherapy; 2016 Dec; 8(12):1363-1369. PubMed ID: 28000537
[TBL] [Abstract][Full Text] [Related]
6. [Malignant progression of an anaplastic ganglioglioma into a glioblastoma multiforme--report on two cases and review of the literature].
Naydenov E; Tzekov C; Minkin K; Nachev S; Marinov M
Khirurgiia (Sofiia); 2009; (2-3):69-74. PubMed ID: 20506796
[TBL] [Abstract][Full Text] [Related]
7. The safety of nivolumab for the treatment of advanced non-small cell lung cancer.
Metro G; Ricciuti B; Brambilla M; Baglivo S; Soli I; Minenza E; Leonardi GC; D'arpino A; Colabrese D; Tazza M; Zicari D; Minotti V; Chiari R
Expert Opin Drug Saf; 2017 Jan; 16(1):101-109. PubMed ID: 27910704
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer.
Tanvetyanon T; Creelan BC; Antonia SJ
Expert Rev Anticancer Ther; 2016 Sep; 16(9):903-10. PubMed ID: 27488231
[TBL] [Abstract][Full Text] [Related]
9. Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient.
Abe J; Sato T; Tanaka R; Okazaki T; Takahashi S
Am J Case Rep; 2016 Nov; 17():880-882. PubMed ID: 27893699
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
[TBL] [Abstract][Full Text] [Related]
11. Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions.
Heiss WD
Cerebrovasc Dis; 2016; 41(1-2):1-7. PubMed ID: 26581023
[TBL] [Abstract][Full Text] [Related]
12. A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis.
Richard K; Weslow J; Porcella SL; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729069. PubMed ID: 28975824
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up monitoring with magnetic resonance tomography after decompressive trephining in experimental "malignant" hemispheric infarct].
Engelhorn T; Dörfler A; Egelhof T; Schwab S; Heiland S; Sartor K; Forsting M
Zentralbl Neurochir; 1998; 59(3):157-65. PubMed ID: 9816666
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Brahmer J; Reckamp KL; Baas P; Crinò L; Eberhardt WE; Poddubskaya E; Antonia S; Pluzanski A; Vokes EE; Holgado E; Waterhouse D; Ready N; Gainor J; Arén Frontera O; Havel L; Steins M; Garassino MC; Aerts JG; Domine M; Paz-Ares L; Reck M; Baudelet C; Harbison CT; Lestini B; Spigel DR
N Engl J Med; 2015 Jul; 373(2):123-35. PubMed ID: 26028407
[TBL] [Abstract][Full Text] [Related]
15. [A 85-year-old woman with one year history of convulsion, dementia, and consciousness disturbance].
Kobayashi T; Takanashi M; Mori H; Suzuki M; Suda K; Takubo H; Mizuno Y
No To Shinkei; 1997 Oct; 49(10):953-61. PubMed ID: 9368896
[TBL] [Abstract][Full Text] [Related]
16. Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion.
Kushnir I; Wolf I
Cardiology; 2017; 136(1):49-51. PubMed ID: 27554835
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma detected at the initial stage in its developmental process -case report-.
Oyama H; Ando Y; Aoki S; Kito A; Maki H; Hattori K; Tanahashi K
Neurol Med Chir (Tokyo); 2010; 50(5):414-7. PubMed ID: 20505302
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Bouffet E; Larouche V; Campbell BB; Merico D; de Borja R; Aronson M; Durno C; Krueger J; Cabric V; Ramaswamy V; Zhukova N; Mason G; Farah R; Afzal S; Yalon M; Rechavi G; Magimairajan V; Walsh MF; Constantini S; Dvir R; Elhasid R; Reddy A; Osborn M; Sullivan M; Hansford J; Dodgshun A; Klauber-Demore N; Peterson L; Patel S; Lindhorst S; Atkinson J; Cohen Z; Laframboise R; Dirks P; Taylor M; Malkin D; Albrecht S; Dudley RW; Jabado N; Hawkins CE; Shlien A; Tabori U
J Clin Oncol; 2016 Jul; 34(19):2206-11. PubMed ID: 27001570
[TBL] [Abstract][Full Text] [Related]
19. Nivolumab-induced aplastic anemia: A case report and literature review.
Comito RR; Badu LA; Forcello N
J Oncol Pharm Pract; 2019 Jan; 25(1):221-225. PubMed ID: 28825374
[TBL] [Abstract][Full Text] [Related]
20. Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.
Pluchart H; Pinsolle J; Cohen J; Ferretti GR; Bedouch P; Giaj Levra M; Toffart AC; Moro-Sibilot D
J Med Case Rep; 2017 Jul; 11(1):183. PubMed ID: 28679408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]